Advanced
search

Search results

1 – 3 of 3
View access options
Executive summary
Publication date: 22 February 2023
Expert Briefings Powered by Oxford Analytica

SERBIA/UAE: Ties will remain strong
View access options
Executive summary
Publication date: 26 August 2016
Expert Briefings Powered by Oxford Analytica

PHILIPPINES/UK: Post-Brexit trade outlook is positive
View access options
Executive summary
Publication date: 25 October 2018
Expert Briefings Powered by Oxford Analytica

IRELAND: Harmonised corporate tax threatens economy

Details

DOI: 10.1108/OXAN-ES239455

ISSN: 2633-304X

Keywords

Geographic
Ireland
EUR
EU
Topical
economy
politics
corporate
fiscal
foreign investment
government
policy
construction
pharmaceutical
technology

Access

Year

Content type

Executive summary (3)
Refine By Country
{"C":[{"count":"1","title":"China","url_remove":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22","url":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22+AND+keyword-country%3A%22China%22"}],"I":[{"count":"1","title":"Ireland","url_remove":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22","url":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22+AND+keyword-country%3A%22Ireland%22"}],"P":[{"count":"1","title":"Philippines","url_remove":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22","url":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22+AND+keyword-country%3A%22Philippines%22"}],"R":[{"count":"1","title":"Russia","url_remove":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22","url":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22+AND+keyword-country%3A%22Russia%22"}],"S":[{"count":"1","title":"Serbia","url_remove":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22","url":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22+AND+keyword-country%3A%22Serbia%22"}],"U":[{"count":"1","title":"United Arab Emirates","url_remove":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22","url":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22+AND+keyword-country%3A%22United+Arab+Emirates%22"},{"count":"1","title":"United Kingdom","url_remove":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22","url":"facet-content-type=oxan-executive-summary&p=1&q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22foreign+investment%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22construction%22+AND+keyword-country%3A%22United+Kingdom%22"}]}
1 – 3 of 3
Manage cookies

We’re listening — tell us what you think

Join us on our journey